🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 4 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/04/2018 | 52,54 | 52,84 | 51,95 | 52,03 | -0,02% | 1,71% | 13.074.638 |
| 04/04/2018 | 51,02 | 52,19 | 50,95 | 52,04 | +0,83% | 2,41% | 9.330.030 |
| 03/04/2018 | 50,90 | 51,67 | 50,41 | 51,61 | +1,54% | 2,47% | 9.688.341 |
| 02/04/2018 | 51,91 | 52,15 | 50,53 | 50,83 | -2,20% | 3,11% | 14.041.104 |
| 29/03/2018 | 52,82 | 52,87 | 51,98 | 51,98 | -1,13% | 1,70% | 10.218.524 |
| 28/03/2018 | 51,57 | 52,81 | 51,55 | 52,57 | +2,49% | 2,44% | 13.302.788 |
| 27/03/2018 | 51,52 | 52,06 | 51,02 | 51,29 | -0,54% | 2,02% | 16.956.535 |
| 26/03/2018 | 51,57 | 51,68 | 50,54 | 51,56 | +1,18% | 2,20% | 10.448.770 |
| 23/03/2018 | 51,83 | 52,20 | 50,90 | 50,96 | -1,31% | 2,52% | 12.408.634 |
| 22/03/2018 | 51,76 | 52,46 | 51,56 | 51,64 | -1,04% | 1,75% | 13.387.990 |
| 21/03/2018 | 52,25 | 52,75 | 51,93 | 52,19 | +0,09% | 1,57% | 10.489.746 |
| 20/03/2018 | 52,24 | 52,42 | 51,87 | 52,14 | +0,02% | 1,06% | 8.153.440 |
| 19/03/2018 | 53,11 | 53,13 | 51,76 | 52,13 | -1,87% | 2,59% | 12.391.762 |
| 16/03/2018 | 52,66 | 53,29 | 52,56 | 53,12 | +0,76% | 1,40% | 22.010.620 |
| 15/03/2018 | 52,43 | 53,18 | 52,38 | 52,72 | +0,82% | 1,53% | 10.560.277 |
| 14/03/2018 | 52,74 | 52,89 | 51,82 | 52,29 | -1,03% | 2,03% | 11.692.222 |
| 13/03/2018 | 53,19 | 53,20 | 52,48 | 52,83 | +0,02% | 1,35% | 12.272.080 |
| 12/03/2018 | 53,18 | 53,56 | 52,71 | 52,82 | +0,40% | 1,60% | 11.269.039 |
| 09/03/2018 | 52,51 | 52,66 | 52,19 | 52,61 | +0,69% | 0,89% | 9.240.006 |
| 08/03/2018 | 52,02 | 52,31 | 51,87 | 52,25 | +0,53% | 0,84% | 7.705.001 |
| 07/03/2018 | 51,37 | 52,08 | 51,29 | 51,98 | +0,31% | 1,54% | 12.817.564 |
| 06/03/2018 | 51,99 | 52,20 | 51,36 | 51,81 | -0,18% | 1,63% | 9.716.951 |
| 05/03/2018 | 51,76 | 52,20 | 51,60 | 51,91 | +0,07% | 1,16% | 13.743.577 |
| 02/03/2018 | 51,03 | 51,94 | 50,69 | 51,87 | +1,23% | 2,45% | 9.355.706 |
| 01/03/2018 | 51,77 | 52,30 | 50,97 | 51,24 | -0,96% | 2,56% | 13.648.523 |
| 28/02/2018 | 52,54 | 52,64 | 51,73 | 51,74 | -0,91% | 1,74% | 11.807.606 |
| 27/02/2018 | 53,35 | 53,40 | 52,19 | 52,21 | -2,39% | 2,25% | 9.734.453 |
| 26/02/2018 | 52,48 | 53,62 | 52,48 | 53,49 | +2,17% | 2,16% | 12.725.026 |
| 23/02/2018 | 52,31 | 52,48 | 52,07 | 52,36 | +0,55% | 0,78% | 9.499.177 |
| 22/02/2018 | 52,10 | 52,55 | 51,93 | 52,07 | +0,04% | 1,19% | 11.334.958 |